Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 11:13AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.96 Insider Own3.32% Shs Outstand289.81M Perf Week-2.20%
Market Cap708.59M Forward P/E- EPS next Y-0.55 Insider Trans0.00% Shs Float280.17M Perf Month4.49%
Income-75.72M PEG- EPS next Q-0.24 Inst Own27.04% Short Float2.61% Perf Quarter6.30%
Sales105.17M P/S6.74 EPS this Y61.32% Inst Trans-2.02% Short Ratio5.17 Perf Half Y-9.11%
Book/sh-1.66 P/B- EPS next Y41.49% ROA-20.08% Short Interest7.30M Perf Year28.68%
Cash/sh0.44 P/C5.50 EPS next 5Y- ROE-117.21% 52W Range1.46 - 3.16 Perf YTD10.63%
Dividend Est.- P/FCF- EPS past 5Y-5.70% ROI-28.02% 52W High-22.63% Beta1.64
Dividend TTM- Quick Ratio2.87 Sales past 5Y-2.21% Gross Margin45.68% 52W Low67.47% ATR (14)0.15
Dividend Ex-Date- Current Ratio3.30 EPS Y/Y TTM58.43% Oper. Margin-66.93% RSI (14)54.54 Volatility6.51% 6.02%
Employees523 Debt/Eq- Sales Y/Y TTM-3.68% Profit Margin-72.00% Recom1.00 Target Price4.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q28.87% Payout- Rel Volume0.37 Prev Close2.35
Sales Surprise7.49% EPS Surprise-17.39% Sales Q/Q-1.09% EarningsFeb 28 AMC Avg Volume1.41M Price2.44
SMA202.34% SMA508.97% SMA2005.65% Trades Volume155,724 Change4.04%
Date Action Analyst Rating Change Price Target Change
Jul-12-23Initiated KeyBanc Capital Markets Overweight $4
Feb-22-24 04:05PM
Feb-14-24 08:30AM
Feb-07-24 08:30AM
Jan-08-24 08:30AM
Jan-05-24 08:46AM
10:23PM Loading…
Jan-04-24 10:23PM
Dec-29-23 05:04PM
Dec-28-23 04:16PM
Dec-26-23 03:59PM
Dec-22-23 06:57PM
Dec-21-23 08:00AM
Dec-20-23 09:00AM
Dec-17-23 03:37PM
Dec-12-23 04:32PM
10:37AM Loading…
Dec-11-23 10:37AM
Dec-06-23 11:18AM
Dec-04-23 08:00AM
Nov-09-23 05:54AM
Nov-08-23 12:47PM
Nov-07-23 04:23PM
Nov-02-23 08:30AM
Oct-25-23 08:30AM
Oct-10-23 10:22AM
Oct-05-23 02:42PM
Oct-04-23 06:49PM
09:06AM Loading…
Aug-09-23 09:06AM
Aug-08-23 05:36PM
Jul-26-23 04:05PM
Jul-25-23 04:05PM
Jul-13-23 07:33AM
Jun-14-23 07:30AM
Jun-13-23 01:30PM
May-25-23 04:05PM
May-24-23 07:11AM
May-18-23 07:30AM
May-15-23 07:30AM
May-10-23 02:47PM
May-09-23 06:11PM
Apr-25-23 04:30PM
Apr-20-23 05:03PM
Apr-18-23 10:42AM
Apr-17-23 08:30AM
Mar-22-23 08:30AM
Mar-15-23 08:30AM
Mar-14-23 08:30AM
Mar-01-23 04:05PM
Feb-21-23 08:30AM
Feb-17-23 06:43PM
Feb-15-23 06:01PM
Feb-14-23 04:05PM
Feb-03-23 05:30AM
Jan-31-23 08:30AM
Jan-09-23 08:30AM
Jan-03-23 08:30AM
Dec-24-22 08:01AM
Nov-28-22 08:30AM
Nov-22-22 09:20AM
Nov-11-22 05:02AM
Nov-08-22 04:05PM
Nov-07-22 04:05PM
Oct-25-22 08:30AM
Oct-13-22 08:30AM
Oct-06-22 08:30AM
Aug-25-22 04:05PM
Aug-14-22 10:38AM
Aug-08-22 04:02PM
Jul-25-22 04:30PM
Jul-04-22 11:56AM
May-05-22 04:02PM
Apr-22-22 04:02PM
Apr-11-22 08:30AM
Apr-05-22 07:30AM
Mar-29-22 08:00AM
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Casdin EliDirectorMay 19Buy2.29800,0001,835,9201,200,000May 19 09:02 PM
Casdin Partners Master Fund, LDirectorMay 19Buy2.29800,0001,835,9201,200,000May 19 09:00 PM
Black Jeffrey G.SVP & Chief Financial OfficerMay 19Buy2.2942,49297,21385,984May 22 06:49 PM
Casdin Partners Master Fund, LDirectorMay 18Buy2.16150,000323,865400,000May 19 09:00 PM
Casdin EliDirectorMay 18Buy2.16150,000323,865400,000May 19 09:02 PM
Black Jeffrey G.SVP & Chief Financial OfficerMay 18Buy2.2243,49296,36543,492May 22 06:49 PM
Casdin EliDirectorMay 17Buy1.89250,000471,550250,000May 19 09:02 PM
Casdin Partners Master Fund, LDirectorMay 17Buy1.89250,000471,550250,000May 19 09:00 PM
Kim Hanjoon AlexChief Operating OfficerApr 04Option Exercise0.0070,183070,183Apr 06 07:05 PM
Egholm MichaelPresident & CEOApr 04Option Exercise0.00196,5120206,512Apr 06 07:02 PM